Large-scale testing (Phase 3)UnknownNCT05737563
What this trial is testing
PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC
Who this might be right for
Esophageal Squamous Cell Carcinoma Abdominal Stage 0
Sun Yat-sen University 380